Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

For better result, minimum character length is four(4)
Results 41 - 50 of 200 for wx. (0.06 seconds)

China-based biopharmas reported higher Q1 revenues...
WuXi PharmaTech Inc. reported Q1 revenues were 69% higher...
Yesterday, WuXi PharmaTech, the Shanghai-based CRO,...
WuXi PhamaTech released positive Q1 results though...
WuXi PharmaTech has extended its collaboration with...
Japan-based Daiichi Sankyo will buy a majority stake in...
Burrill & Company, together with BIOCOM, hosted the...
Last week, much of the news about China’s...
WuXi PharmaTech and Covance Inc. signed a Memorandum of...
Last week witnessed the formation of an unusually high...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | next
Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here